|
MechanismHSV- ICP0 inhibitors [+2] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with HSV- ICP0
100 Translational Medicine associated with HSV- ICP0
0 Patents (Medical) associated with HSV- ICP0